DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Retrovir (Zidovudine) - News

 
 



News related to Retrovir (Zidovudine) and/or conditions it is approved for

Antiretrovirals Linked to Liver Fibrosis
Source: Medscape Gastroenterology Headlines [2013.05.14]
A recent study looked for predictors of advanced fibrosis, which affects many patients coinfected with hepatitis B and HIV.
Medscape Medical News

Highly Active Antiretroviral Therapies May Be Cardioprotective In HIV-Infected Children, Teens
Source: HIV / AIDS News From Medical News Today [2013.04.22]
Long-term use of highly active antiretroviral therapies (HAART) does not appear to be associated with impaired heart function in children and adolescents in a study that sought to determine the cardiac effects of prolonged exposure to HAART on children infected with the human immunodeficiency virus (HIV), according to a report published Online First by JAMA Pediatrics, a JAMA Network publication...

Psychoactivity Of HIV Antiretroviral Drug Leads To Recreational Use
Source: HIV / AIDS News From Medical News Today [2013.04.22]
More than 1 in 270 people in the US are living with HIV and every 9.5 minutes someone is else is infected. The economic cost estimates associated with HIV/AIDS exceed 36 billion dollars a year...

Antiretroviral Therapy Not Found To Affect Resting Energy Expenditure Among Women With HIV
Source: HIV / AIDS News From Medical News Today [2013.04.18]
Studies have shown that about 10 percent of men infected with human immunodeficiency virus (HIV) have an elevated resting energy expenditure (REE). Their bodies use more kilocalories for basic functions including circulation, body temperature, and breathing. Most studies have been conducted in men and those with solely women have had small sample sizes...

Researchers Aiming To Prevent HIV 'Reservoirs' From Forming
Source: HIV / AIDS News From Medical News Today [2013.04.19]
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated. HIV-1 is the virus that causes AIDS, and the discovery could lead to novel approaches for addressing HIV-1 "in hiding" - namely eliminating reservoirs of HIV-1 that persist in patients undergoing antiretroviral therapy...

Treatment Leads To Near-Normal Life Expectancy For People With HIV In South Africa
Source: HIV / AIDS News From Medical News Today [2013.04.09]
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count drops below 200 (cells per microliter), according to a study by South African researchers published in this week's PLOS Medicine...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012